MelanomaReAlli | Laying the Groundwork for Patient-Centric Research @MelanomaReAlli | Uploaded 2 years ago | Updated November 19 2023
MRA's Senior Director of Scientific Program Kristen Mueller hosts conversation between Rising Tide Foundation for Clinical Cancer Research's Senior Scientific Program Manager Alexandre Alencar, and melanoma survivor and patient advocate T.J. Sharpe discuss the importance of patient centricity in clinical research.
This video provides examples and gives context to upcoming requirements to apply for a special opportunity supported by MRA and RTFCC that will be released in early September.
The special opportunity is anticipated to support up to $1.5 million for each of the two awards, over a five-year period. Critical to these opportunities will be a patient-centric approach, where patients are engaged early on, and throughout the project in designing/refining/and guiding of such research efforts to ensure patient needs and preferences are front and center.
Learn more and subscribe to the RFP at www.curemelanoma.org/RFP
MRA's Senior Director of Scientific Program Kristen Mueller hosts conversation between Rising Tide Foundation for Clinical Cancer Research's Senior Scientific Program Manager Alexandre Alencar, and melanoma survivor and patient advocate T.J. Sharpe discuss the importance of patient centricity in clinical research.
This video provides examples and gives context to upcoming requirements to apply for a special opportunity supported by MRA and RTFCC that will be released in early September.
The special opportunity is anticipated to support up to $1.5 million for each of the two awards, over a five-year period. Critical to these opportunities will be a patient-centric approach, where patients are engaged early on, and throughout the project in designing/refining/and guiding of such research efforts to ensure patient needs and preferences are front and center.
Learn more and subscribe to the RFP at www.curemelanoma.org/RFP
